VeGen Labs is a precision oncology company targeting cancer with high unmet medical need. Our approach of drug development is a departure from the conventional models, with our goal to substantial cost savings, that further manifests in the pricing of our medicines. We plan to achieve this by:
Access to proprietary treatments available in the west, continue to remain limited in major Asia countries including India, majorly due to lack of insurance coverage, making it a financial burden for patients with advanced or metastatic late-stage disease.
At VeGen we are revolutionizing the way we conceive, develop, and deliver groundbreaking medications, reimagining partnerships across the entire drug development spectrum to bring accessible and affordable treatment to patients.